What Analysts Are Saying About NCS Multistage After the Quiet Period

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
What Analysts Are Saying About NCS Multistage After the Quiet Period

© Thinkstock

NCS Multistage Holdings Inc. (NASDAQ: NCSM) saw its shares pullback in Tuesday’s session after the company’s quiet period came to an end. NCS originally came public in its late-April initial public offering (IPO). Most analysts were fairly positive on the stock, although there was a little trepidation from one firm.

24/7 Wall St. has included some recent highlights from NCS, as well as what analysts are saying after the quiet period.

The stock entered the market on April 28 around $20 per share, despite pricing at $17 per share. Overall, there were 9.5 million shares in the offering, which raised gross proceeds over $160 million.

The underwriters for the offering were Credit Suisse, Citigroup, Wells Fargo, JPMorgan, Simmons, Raymond James, RBC Capital Markets and Tudor Pickering Holt.

[wallst_email_signup]

Credit Suisse started NCS as Outperform with a $27 target, calling it a differentiated play:

In a highly commoditized industry, NCSM represents a potentially disruptive technology with the best return and FCF metrics in the industry. NCSM has 26% of the entire Canadian horizontal completions market and less than 1% of U.S. market share, both of which are accelerating (first quarter revenues increased about 70% quarter over quarter, and the brokerage firm models 2017 revenues up roughly 160% year over year.) The business model is compelling, with capex being the lowest in our sector, relative to revenues or EBITDA, and returns on tangible assets over the past four years the highest in the industry.

Wells Fargo and RBS both started NCS with an Outperform rating, with a $35 target price from the former and a $29 price target from the latter. Piper Jaffray started it as Overweight, with a $28 price target.

JPMorgan was the only firm that took a sideline view of the stock, with a Neutral rating and a $24 price target.

For some background: NCS is a leading provider of highly engineered products and support services that facilitate the optimization of oil and natural gas well completions and field development strategies. It provides products and services primarily to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations.

Shares of NCS were trading down 3.7% at $23.11 on Tuesday, with a post-IPO trading range of $19.25 to $24.45.

[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618